Showing 20 of 45 recruiting trials for “Meningioma”
Comparison of Skin Closure Techniques in Oncological Neurosurgical Procedures: Intradermal Running Suture Versus Transdermal Interrupted Sutures
👨⚕️ Michał Senger, M.D., Department of Neurosurgery, Medical University of Warsaw, Warsaw, Poland📍 1 site📅 Started Feb 2026View details ↗
Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma
👨⚕️ Joshua D Palmer, MD, Ohio State University Comprehensive Cancer Center📍 1 site📅 Started Nov 2025View details ↗
Proton Versus Photon Radiotherapy in Adults With Primary Brain Tumors
RecruitingNCT07044076 ↗
Translation and Validation of the MQOL Self-questionnaire Into French for Assessing Quality of Life in Patients With Meningiomas
Abemaciclib in Newly Diagnosed Meningioma Patients
RecruitingNCT06874426 ↗
The Impact of Endoscopic Endonasal Skull Base Surgery on Olfaction
177Lu-DOTATATE for Recurrent Meningioma
Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial
👨⚕️ Kimberly Hoang, MD, Emory University Hospital/Winship Cancer Institute📍 1 site📅 Started Jan 2025View details ↗
Robot-Assisted Neurovascular Intervention
Somatostatin Receptor PET Imaging to Guide Radiotherapy Dose Escalation in High Risk Meningiomas.
👨⚕️ Lorenzo Vinante, Centro di Riferimento Oncologico di Aviano (CRO)📍 1 site📅 Started Dec 2024View details ↗
RecruitingNCT06709833 ↗
Meningioma and Embolism Thrombosis Risk & Investigation of Coagulation
Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma
👨⚕️ William Chen, MD, University of California, San Francisco📍 1 site📅 Started Dec 2024View details ↗
Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors
👨⚕️ Robert M Prins, UCLA / Jonsson Comprehensive Cancer Center📍 1 site📅 Started Dec 2024View details ↗
Combination of Everolimus and 177Lu-DOTATATE in the Treatment of Grades 2 and 3 Refractory Meningioma: a Phase IIb Clinical Trial
TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas
RecruitingNCT07282470 ↗
Epigenetic Profiling and Liquid Biopsy: Perspectives for Personalized Medicine in Meningioma Patients - MIND
Regorafenib for Recurrent Meningioma (MIRAGE Trial)
👨⚕️ Giuseppe Lombardi, MD, Istituto Oncologico Veneto IOV IRCCS📍 17 sites📅 Started Sep 2024View details ↗
Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE
👨⚕️ Jana Ivanidze, MD/PhD, Weill Medical College of Cornell University📍 1 site📅 Started Sep 2024View details ↗
A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors
Page 1 of 3Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →